<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<ArticleSet>
<Article>
<Journal>
<PublisherName>jmedicalcasereports</PublisherName>
<JournalTitle>Frontiers in Medical Case Reports</JournalTitle>
<PISSN>I</PISSN>
<EISSN>S</EISSN>
<Volume-Issue>Volume 1; Issue 6</Volume-Issue>
<PartNumber/>
<IssueTopic>Multidisciplinary</IssueTopic>
<IssueLanguage>English</IssueLanguage>
<Season>(Nov-Dec, 2020)</Season>
<SpecialIssue>N</SpecialIssue>
<SupplementaryIssue>N</SupplementaryIssue>
<IssueOA>Y</IssueOA>
<PubDate>
<Year>-0001</Year>
<Month>11</Month>
<Day>30</Day>
</PubDate>
<ArticleType>Medical Case Reports</ArticleType>
<ArticleTitle>Anaplastic Large Cell Lymphoma Associated with Breast Implant (LACG - AIM): A Case Report and Literature Review</ArticleTitle>
<SubTitle/>
<ArticleLanguage>English</ArticleLanguage>
<ArticleOA>Y</ArticleOA>
<FirstPage>1</FirstPage>
<LastPage>14</LastPage>
<AuthorList>
<Author>
<FirstName>Nuvia Aliaga</FirstName>
<LastName>M</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>N</CorrespondingAuthor>
<ORCID/>
<FirstName>Mauricio</FirstName>
<LastName>Oyarzo</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>Y</CorrespondingAuthor>
<ORCID/>
<FirstName>Paola</FirstName>
<LastName>Aravena</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>Y</CorrespondingAuthor>
<ORCID/>
<FirstName>Patricia</FirstName>
<LastName>Arancibia</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>Y</CorrespondingAuthor>
<ORCID/>
<FirstName>Maria De Los Angeles</FirstName>
<LastName>Rodriguez</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>Y</CorrespondingAuthor>
<ORCID/>
<FirstName>Alvaro</FirstName>
<LastName>Ibarra</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>Y</CorrespondingAuthor>
<ORCID/>
<FirstName>Ricardo</FirstName>
<LastName>Schwartz</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>Y</CorrespondingAuthor>
<ORCID/>
<FirstName>Hernando</FirstName>
<LastName>Paredes</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>Y</CorrespondingAuthor>
<ORCID/>
<FirstName>Carolina Gonzalez</FirstName>
<LastName>Valdes</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>Y</CorrespondingAuthor>
<ORCID/>
</Author>
</AuthorList>
<DOI/>
<Abstract>The clinical case of a 48-year-old patient with BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA (BIA-ALCL) is presented. The clinical presentation, diagnosis methods, and treatment are described.
The case is combined with a bibliographic review that summarizes and analyses the history and epidemiology of this emerging pathology, of low incidence, but with a discrete malignant potential.
The growing use of breast implants around the world, both in breast reconstruction and aesthetics, makes be aware of new publications that increase more robust evidence to the knowledge of this entity.</Abstract>
<AbstractLanguage>English</AbstractLanguage>
<Keywords>BIA-ALCL (Breast Implant-Associated Anaplastic Large Cell Lymphoma),Clinical Presentation,Diagnosis,Therapy,Incidence</Keywords>
<URLs>
<Abstract>https://www.jmedicalcasereports.org/ubijournal-v1copy/journals/abstract.php?article_id=8702&title=Anaplastic Large Cell Lymphoma Associated with Breast Implant (LACG - AIM): A Case Report and Literature Review</Abstract>
</URLs>
<References>
<ReferencesarticleTitle>References</ReferencesarticleTitle>
<ReferencesfirstPage>16</ReferencesfirstPage>
<ReferenceslastPage>19</ReferenceslastPage>
<References>Adrada BE, Miranda RN, Rauch GM, Arribas E, Kanagal-Shamanna R, Clemens MW, Fanale M, Haideri N, Mustafa E, Larrinaga J, Reisman NR. Breast implant-associated anaplastic large cell lymphoma: sensitivity, specificity, and findings of imaging studies in 44 patients. Breast Cancer Res Treat 2014; 147: 1-14.
Brody GS, Deapen D, Gill P, Epstein A, Martin S, Elatra W. T cell non-Hodgkin’s anaplastic lymphoma associated with one style of breast implants. San Antonio, Texas. American Society of Plastic Surgeons Annual Conference; March 20–23, 2010; Scientific Session IX: Breast B, Oral communication and abstract. Available at: https://aaps1921.org/2010-Program.cgi (Accessed July 2020)
Brody GS, Deapen D, Taylor CR, Pinter-Brown L, House-Lightner SR, Andersen JS, Carlson G, Lechner MG, Epstein AL. Anaplastic large cell lymphoma occurring in women with breast implants: analysis of 173 cases. Plast Reconstr Surg 2015; 135: 695-705.
Brody GS, Deapen D, Taylor CR, Pinter-Brown L, House-Lightner SR, Andersen JS, Carlson G, Lechner MG, Epstein AL. Anaplastic large cell lymphoma occurring in women with breast implants: analysis of 173 cases. Plast Reconstr Surg 2015; 135: 695-705.
Center for Devices and Radiological Health Food and Drug Administration (FDA). Update on the safety of silicone gel-filled breast implants. Published June, 2011. Available at: https://www.fda.gov/files/medical%20devices/published/Update-on-the-Safety-of-Silicone-Gel-Filled-Breast-Implants-%282011%29.pdf (Accessed July 2020)
Clemens Mark W. Linfoma anapland;aacute;sico de cand;eacute;lulas grandes asociado a implantes mamarios (LACG-AIM): capeando los desafand;iacute;os de un clima rand;aacute;pidamente cambiante. Cir Pland;aacute;st Iberolatinoam 2020; 45: 215-220.
Clemens MW, Brody GS, Mahabir RC, Miranda RN. How to Diagnose and Treat Breast Implant-Associated Anaplastic Large Cell Lymphoma. Plast Reconstr Surg 2018; 141: 586e-599e.
Clemens MW, Jacobsen ED, Horwitz SM. 2019 NCCN Consensus Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). Aesthet Surg J 2019; 39: S3-S13.
Clemens MW, Medeiros LJ, Butler CE, Hunt KK, Fanale MA, Horwitz S, Weisenburger DD, Liu J, Morgan EA, Kanagal-Shamanna R, Parkash V, Ning J, Sohani AR, Ferry JA, Mehta-Shah N, Dogan A, Liu H, Thormann N, Di Napoli A, Lade S, Piccolini J, Reyes R, Williams T, McCarthy CM, Hanson SE, Nastoupil LJ, Gaur R, Oki Y, Young KH, Miranda RN. Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant-Associated Anaplastic Large-Cell Lymphoma. J Clin Oncol 2016; 34: 160-168.
Clemens MW. Linfoma anapland;aacute;sico de cand;eacute;lulas grandes asociado a implantes mamarios (LACG-AIM): capeando los desafand;iacute;os de un clima rand;aacute;pidamente cambiante. Cir Pland;aacute;st Iberolatinoamericana 2019; 45: 215-2018.
Cordeiro PG, Ghione P, Ni A, Hu Q, Ganesan N, Galasso N, Dogan A, Horwitz SM. Risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3546 women prospectively followed long term after reconstruction with textured breast implants. J Plast Reconstr Aesthet Surg 2020; 73: 841-846.
de Boer M, van Leeuwen FE, Hauptmann M, Overbeek LIH, de Boer JP, Hijmering NJ, Sernee A, Klazen CAH, Lobbes MBI, van der Hulst RRWJ, Rakhorst HA, de Jong D. Breast Implants and the Risk of Anaplastic Large-Cell Lymphoma in the Breast. JAMA Oncol 2018; 4: 335-341.
Doren EL, Miranda RN, Selber JC, Garvey PB, Liu J, Medeiros LJ, Butler CE, Clemens MW. U.S. Epidemiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma. Plast Reconstr Surg 2017; 139: 1042-1050.
Eisenberg AM, Eppelheimer CN, Fulop TA, Abramson LL. Case 256: Breast Implant-associated Anaplastic Large-Cell Lymphoma. Radiology 2018; 288: 624-629.
FDA News Release. FDA takes action to protect patients from risk of certain textured breast implants; requests Allergan voluntarily recall certain breast implants and tissue expanders from market. July 24,2019. Available at: https://www.fda.gov/news-events/press-announcements/fda-takes-action-protect-patients-risk-certain-textured-breast-implants-requests-allergan (Accessed July 2020)
FDA. Advisory Committee Meeting. March 25-26, 2019: General and Plastic Surgery Devices Panel of the Medical Devices Advisory Committee Meeting Announcement. Available at: https://www.fda.gov/advisory-committees/advisory-committee-calendar/march-25-26-2019-general-and-plastic-surgery-devices-panel-medical-devices-advisory-committee (Accessed July 2020)
Food and Drug Administration (FDA). Medical Devices. Products and Medical Procedures. Implants and Prosthetics. Breast Implants. Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). U.S. Food and Drug Administration (FDA). 2018. Available at: http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/BreastImplants/ucm239995.htm (Accessed July 2020)
Food and Drug Administration (FDA). Safety communication on BIA – ALCL. 2019 July 24. Available at: https://www.fda.gov/news-events/press-announcements/fda-takes-action-protect-patients-risk-certain-textured-breast-implants-requests-allergan (Accessed Aug 2020)
Food and Drug Administration (FDA). WARNING LETTER Mentor Worldwide LLC and; Acclarent MARCS-CMS 573520 — MARCH 18, 2019 Available at https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/mentor-worldwide-llc-acclarent-573520-03182019 (Accessed July 2020)
Food and Drug Administration (FDA). WARNING LETTER Sientra Inc MARCS-CMS 573436 — MARCH 18, 2019. Available at https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/sientra-inc-573436-03182019 (Accessed July 2020)
Groth A, Graf R. Linfoma anapland;aacute;sico de cand;eacute;lulas grandes asociado a implantes mamarios (BIA-ALCL) y la crisis de implantes mamarios texturizados. Aesth Plast Surg 2020; 44: 1-12.
Keech JA Jr and Creech BJ. Anaplastic T-cell lymphoma in proximity to a saline-filled breast implant. Plast Reconstr Surg 1997; 100: 554-555.
Laurent C, Haioun C, Brousset P, Gaulard P. New insights into breast implant-associated anaplastic large cell lymphoma. Curr Opin Oncol 2018; 30: 292-300.
Laurent C, Nicolae A, Laurent C, Le Bras F, Haioun C, Fataccioli V, Amara N, Adand;eacute;laand;iuml;de J, Guille A, Schiano JM, Tesson B, Traverse-Glehen A, Chenard MP, Mescam L, Moreau A, Chassagne-Clement C, Somja J, Escudiand;eacute; F, Andrand;eacute; M, Martin N, Lacroix L, Lemonnier F, Hamy AS, Reyal F, Bannier M, Oberic L, Prade N, Frand;eacute;nois FX, Beldi-Ferchiou A, Delfau-Larue MH, Bouabdallah R, Birnbaum D, Brousset P, Xerri L, Gaulard P. Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL. Blood 2020; 135: 360-370.
Loch-Wilkinson A, Beath KJ, Knight RJW, Wessels WLF, Magnusson M, Papadopoulos T, Connell T, Lofts J, Locke M, Hopper I, Cooter R, Vickery K, Joshi PA, Prince HM, Deva AK. Breast Implant-Associated Anaplastic Large Cell Lymphoma in Australia and New Zealand: High-Surface-Area Textured Implants Are Associated with Increased Risk. Plast Reconstr Surg 2017; 140: 645-654.
Magnusson M, Beath K, Cooter R, Locke M, Prince HM, Elder E, Deva AK. The Epidemiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma in Australia and New Zealand Confirms the Highest Risk for Grade 4 Surface Breast Implants. Plast Reconstr Surg 2019; 143: 1285-1292.
Marra A, Viale G, Pileri SA, Pravettoni G, Viale G, De Lorenzi F, Noland;egrave; F, Veronesi P, Curigliano G. Breast implant-associated anaplastic large cell lymphoma: A comprehensive review. Cancer Treat Rev 2020; 84: 101963.
McCarthy CM, Loyo-Berrand;iacute;os N, Qureshi AA, Mullen E, Gordillo G, Pusic AL, Ashar BS, Sommers K, Clemens MW. Patient Registry and Outcomes for Breast Implants and Anaplastic Large Cell Lymphoma Etiology and Epidemiology (PROFILE): Initial Report of Findings, 2012-2018. Plast Reconstr Surg 2019; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma): 65S-73S.
Mehta-Shah N, Clemens MW, Horwitz SM. How I treat breast implant-associated anaplastic large cell lymphoma. Blood 2018; 132: 1889-1898.
Scientific Committee on Health Environmental and Emerging Risks (SCHEER). SCIENTIFIC ADVICE ON The state of scientific knowledge regarding a possible connection between breast implants and anaplastic large cell lymphoma. 19 October 2017. Available at: https://ec.europa.eu/health/sites/health/files/scientific_committees/scheer/docs/scheer_o_007.pdf. (Accessed July 2020)
Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD, Jaffe ES. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016; 127: 2375-2390.
Torres Pand;eacute;rez A, Gijand;oacute;n Vega M, Kenig N, Montand;oacute;n Echeverrand;iacute;a J, Gand;oacute;mez Bajo G J, Vaquero Pand;eacute;rez M del M. Linfoma anapland;aacute;sico de cand;eacute;lulas grandes e implantes mamarios: revisiand;oacute;n sistemand;aacute;tica de las casuand;iacute;sticas publicadas. Cir pland;aacute;st iberolatinoam 2020; 46: 25-36.
Zerga M. Linfoma a grandes cand;eacute;lulas anapland;aacute;sico asociado a implantes mamarios. Artand;iacute;culo de revisiand;oacute;n. Hematologand;iacute;a 2018; 22: 288-294.</References>
</References>
</Journal>
</Article>
</ArticleSet>